Position in ABBV
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$8,949,713
-$499,719 QoQ
Shares Held
41,150
-0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026EXENCIAL WEALTH ADVISORS, LLC holds $76,718,350 across 13 Drug Manufacturers - General names. ABBV ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
108,594 | $16,587,733 | |
| 2 | LLY |
ELI LILLY & Co
|
17,141 | $15,765,777 | |
| 3 | JNJ |
Johnson & Johnson
|
41,920 | $10,246,924 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
41,150 | $8,949,713 | |
| 5 | AMGN |
Amgen Inc
|
17,401 | $6,122,541 | |
| 6 | AZN |
Astrazeneca PLC
|
20,162 | $3,976,349 | |
| 7 | SNY |
Sanofi
|
81,382 | $3,920,984 | |
| 8 | GSK |
GSK plc
|
55,198 | $3,046,377 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,949,713 | 41,150 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $9,449,432 | 41,356 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $9,565,148 | 41,311 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $7,407,351 | 39,906 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $8,877,362 | 42,370 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $7,686,235 | 43,254 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $8,750,931 | 44,313 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $8,051,834 | 46,944 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,238,297 | 50,732 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $8,341,415 | 53,826 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,904,248 | 59,736 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,849,201 | 65,681 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $10,423,594 | 65,405 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $11,064,467 | 68,464 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,031,259 | 67,292 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $10,730,849 | 70,063 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $11,409,788 | 70,383 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $9,209,637 | 68,018 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,966,460 | 64,582 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $6,821,365 | 60,559 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,791,021 | 62,752 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $6,286,919 | 58,674 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $10,419,180 | 118,954 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,106,992 | 62,202 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $388,492 | 5,099 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||